Experimental Medicine Training Initiative
  log in
  log in
Cambridge University
Cambridge University



04/04/2017 to 04/04/2017

• Understanding the role of immunotherapies in modern drug development.
• Learning novel approaches clinical development of immunotherapies phase 1-4 (pathway to approval).
• Designing novel immunotherapies and identifying pitfalls in developing biologics.
• Key pharmacokinetic (PK) and pharmacodynamic (PD) concepts
·Application of PK/PD through research and development
·Basic PK characteristics of protein drugs
·Biomarker strategies
· Dose selection for First-in Human (FIH) clinical studies
• Understanding how to use experimental medicine to understand the human immune system & use novel statistical study designs to achieve reproducible results.


Day 1 | Tuesday 04 April 2017

Time Item
12:00 to 13:00 Registration and Lunch
13:00 to 13:05 Introduction to the day
Dr Joseph Cheriyan (CUH)
13:05 to 13:40 Journey of a biological molecule - Overview of drug development
Key Note Speaker: Dr Nic Wisniacki (GSK)
13:40 to 13:50 Q&A
13:50 to 14:30 Key technologies and challenges in pre-clinical biologics drug discovery
Dr Steve Martin (GSK). Dr Andrew Buchanan (Medimmune)
14:30 to 15:20 Biologics Interactive workshop and Q&A
Dr Steve Martin & Dr Andrew Buchanan
15:20 to 15:50 Break
15:50 to 16:30 Dose Selection for First-in-Human Studies of Biologics
Dr Paolo Vicini (MedImmune)
16:30 to 17:10 Immune Cell Responses in Participants with Type 1 Diabetes after doses of Interleukin-2 in adaptive-response clinical trials
Dr Frank Waldron-Lynch (University of Cambridge)
17:10 to 18:00 PK/PD Interactive workshop and Q&A
Dr Frank Waldron-Lynch & Dr Paolo Vicini
18:00 to 18:30 Immunopharmacology Group discussion, reflection and review
Lecturer/workshop leads
18:30 to 19:00 Close of Meeting
Depart for Trinity Hall (dinner registrants only)
19:00 to 23:00 Drinks reception followed by dinner
Trinity Hall, Cambridge


Meeting Details

Wyng Gardens Conference Centre, Cambridge, CB5 8AQ

  CPD Points

 Book Now!


Forthcoming Meetings

Paediatric Drug Development

08/10/2018 to 08/10/2018

To understand paediatric drug development in experimental medicine research and as part of clinical studies. Gain an overview of differing disease epidemiology and regulatory considerations, understanding conditions which occur in paediatric populations & adult populations. To understand the difficulties in ...




Copyright ©2018 Experimental Medicine Training Initiative - Cambridge University Hospitals. All rights reserved.